Citigroup analyst Daniel Grosslight downgrades Change Healthcare (NASDAQ:CHNG) from Buy to Neutral.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/20/2022 | $26.00 → $27.75 | Overweight → Neutral | Piper Sandler |
| 9/20/2022 | $27.75 | Buy → Neutral | Citigroup |
| 9/7/2022 | $27.75 | Hold | Truist |
| 4/1/2022 | $25.75 | Neutral | Credit Suisse |
| 2/4/2022 | $25.75 | Neutral → Buy | Citigroup |
EDEN PRAIRIE, Minn. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Optum, a diversified health services company and part of UnitedHealth Group (NYSE: UNH), and Change Healthcare (NASDAQ: CHNG), a health care technology leader, have agreed to combine. Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone. This combination unites two technology and service companies focused on serving health care. Their combined capabilities will more effectively connect and simplify core clinical, administrative and payment processes - resu
AM Best has commented that the Credit Ratings (ratings) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) and its insurance subsidiaries remain unchanged following its completed acquisition of Change Healthcare Inc. (Change Healthcare) (Nashville, TN) (NASDAQ:CHNG), a leading health care technology company. The outlooks of these Credit Ratings (ratings) remain stable. The close of this transaction had been delayed following the antitrust suit from the U.S. Department of Justice; however, the U.S. federal judge cleared the way for the transaction to be completed late in September. The close of the transaction was announced on Oct. 3, 2022. The transaction i
Yesterday, the U.S. District Court for the District of Columbia issued an opinion and final appealable order denying the request made by the U.S. Department of Justice and the States of New York and Minnesota for the Court to enjoin UnitedHealth Group Incorporated (NYSE:UNH) ("UnitedHealth Group") from acquiring Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare") pursuant to the proposed merger (the "Merger") between the Company and a wholly owned subsidiary of UnitedHealth Group, which will result in the combination of the Company and Optum Insight, a part of UnitedHealth Group. The opinion and final appealable order also require UnitedHealth Group and the Compan
Revenue growth driven by continued momentum in core business and investment in expanded capabilities Total revenue of $884M, including solutions revenue of $831M; solutions revenue growth of 1.8% driven by increased volume and new sales Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the first quarter of fiscal year 2023 ended June 30, 2022. "Our first quarter growth, despite headwinds from lower COVID-related activities and customer attrition related to the extended merger process, demonstrates the underlying momentum in the business," said Neil de Crescenzo, president and chief
SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)
SC 13D - Change Healthcare Inc. (0001756497) (Subject)
SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
15-12G - Change Healthcare Inc. (0001756497) (Filer)
S-8 POS - Change Healthcare Inc. (0001756497) (Filer)
25-NSE - Change Healthcare Inc. (0001756497) (Subject)
AM Best has commented that the Credit Ratings (ratings) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) and its insurance subsidiaries remain unchanged following its completed acquisition of Change Healthcare Inc. (Change Healthcare) (Nashville, TN) (NASDAQ:CHNG), a leading health care technology company. The outlooks of these Credit Ratings (ratings) remain stable. The close of this transaction had been delayed following the antitrust suit from the U.S. Department of Justice; however, the U.S. federal judge cleared the way for the transaction to be completed late in September. The close of the transaction was announced on Oct. 3, 2022. The transaction i
Yesterday, the U.S. District Court for the District of Columbia issued an opinion and final appealable order denying the request made by the U.S. Department of Justice and the States of New York and Minnesota for the Court to enjoin UnitedHealth Group Incorporated (NYSE:UNH) ("UnitedHealth Group") from acquiring Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare") pursuant to the proposed merger (the "Merger") between the Company and a wholly owned subsidiary of UnitedHealth Group, which will result in the combination of the Company and Optum Insight, a part of UnitedHealth Group. The opinion and final appealable order also require UnitedHealth Group and the Compan
Revenue growth driven by continued momentum in core business and investment in expanded capabilities Total revenue of $884M, including solutions revenue of $831M; solutions revenue growth of 1.8% driven by increased volume and new sales Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the first quarter of fiscal year 2023 ended June 30, 2022. "Our first quarter growth, despite headwinds from lower COVID-related activities and customer attrition related to the extended merger process, demonstrates the underlying momentum in the business," said Neil de Crescenzo, president and chief
Raymond James reiterates a Strong Buy rating on UnitedHealth Group Inc (NYSE:UNH) while raising the price target to $635 from $620 as a U.S. judge gave a green signal for Change Healthcare Inc's (NASDAQ:CHNG) acquisition. The ruling ended a 21-month fight between UnitedHealth and regulators. The analyst John Ransom writes that the deal is expected to close within ten days of the judge's decision, but DOJ is "evaluating next steps," and there is a slight chance of an appeal and further delay. For modeling purposes, the analyst assumes the deal closes October 1. Adding in the CHNG deal, Raymond James is increasing the 2022 EPS estimate by $0.11 to $21.96 and the 2023 EPS estimate by $0
Gainers SOBR Safe, Inc. (NASDAQ:SOBR) shares surged 232.8% to settle at $3.03 on Tuesday following a report suggesting The National Transportation Safety Board is recommending that NHTSA require passive alcohol-detection systems. The company is engaged in developing alcohol-detecting devices to address the automotive alcohol sensing spectrum. Amprius Technologies, Inc. (NYSE:AMPX) shares jumped 86.4% to close at $11.00 on Tuesday. Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) surged 60.6% to settle at $2.2005. NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) gained 42.4% to close at $20.79. Strength may be due to short interest in the stock and social media interest. Virax Biolabs Group
Piper Sandler downgraded Change Healthcare from Overweight to Neutral and set a new price target of $27.75 from $26.00 previously
Citigroup downgraded Change Healthcare from Buy to Neutral and set a new price target of $27.75
Truist initiated coverage of Change Healthcare with a rating of Hold and set a new price target of $27.75